TABLE 1.

Demographic characteristics of included patients (n = 12)

% Female	67%
Mean age (SD)	45.2 (15.7)
Mean BMI (SD)	30.2 (5.2)
% Tobacco users	42%
Mean Hs‐CRP, ng/L (SD)	Baseline	Week 10
	3.8 (4.7)	2.6 (3.5)
% SSRI users	42%
% SNRI users	50%
% NDRI users	17%
% Antipsychotics users	0%
% Mood stabilizers users	17%
% Previously treated with ECT	33%
Anxiety disorder co‐morbidity (%)	50%
Median number of previous antidepressant trials (range)	5 (2–14)
>50% decrease on MADRS, responder (%)	33%
>50% decrease on SHAPS, responder (%)	25%
Mean pramipexole, mg salt/day, at week 10 (SD)	3.63 mg salt/day (0.70)